Skip to main content
Back to Shunwei Capital

Shunwei Capital's Therapeutics Portfolio

Browse 3 Therapeutics companies funded by Shunwei Capital. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
3
Total Funding in Therapeutics
$73.8M

Therapeutics Portfolio Companies (3)

Export
Alternative MedicineArtificial Intelligence (AI)BiotechnologyGeneticsTherapeutics

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Brisbane, United States
April 2026
Corporate Round

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

VelaVigo is a start-up company engaged in macromolecular biopharmaceutical.

Shanghai, China
July 2025
$60.0M
Seed

Founder Contacts

19,000+ verified contacts

MedicalPharmaceuticalTherapeutics

Farber Xintian CRO company engaged in clinical services of radionuclide drugs.

December 2024
$13.8M
Series A

Founder Contacts

19,000+ verified contacts

Explore Shunwei Capital's Full Portfolio

View all companies funded by Shunwei Capital across every industry and funding stage.

View Full Shunwei Capital Portfolio